Understanding diabetes management in patients with end-stage kidney disease
Pharmaco-epidemiology of diabetes in patients with end-stage kidney disease
This study looks at how people with diabetes and severe kidney disease are treated, focusing on the risks of low and high blood sugar, to see how different diabetes medications affect their health and hospital visits, especially for those in minority groups who are more affected by these issues.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-11042745 on NIH RePORTER |
What this research studies
This research investigates how diabetes is managed in patients with end-stage kidney disease (ESKD), particularly focusing on the risks of severe complications like hypoglycemia and hyperglycemia. By analyzing data from the United States Renal Data System, the study aims to identify current treatment patterns and their effects on health outcomes, including hospitalizations and mortality rates. The research also seeks to understand how different diabetes medications impact these risks, especially among minority populations disproportionately affected by these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults over 21 years old who have diabetes and are undergoing dialysis for end-stage kidney disease.
Not a fit: Patients without diabetes or those not on dialysis for end-stage kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diabetes management strategies for patients with end-stage kidney disease, potentially reducing severe complications and hospitalizations.
How similar studies have performed: Previous research has indicated significant challenges in managing diabetes in patients with ESKD, suggesting that this area of study is both relevant and necessary for improving patient outcomes.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Galindo, Rodolfo — University of Miami School of Medicine
- Study coordinator: Galindo, Rodolfo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.